Quitting tobacco can be considered while someone is receiving or exploring care for another substance-use concern. Tobacco dependence deserves attention as a health issue, not as a judgment about commitment to recovery. The important questions are what the evidence shows, what it cannot establish, and which professional can help address personal health and treatment needs.
A 2025 longitudinal study found an association between stopping cigarette smoking and recovery from non-tobacco substance use disorders. That finding is encouraging, but it does not prove that quitting caused recovery. Separately, federal sources establish health benefits of quitting smoking and describe cessation support options. These are related kinds of evidence, but they answer different questions.
How can tobacco use and substance-use recovery overlap?
Tobacco use and another substance-use disorder can occur together. A 2025 study of cigarette smoking during recovery found that transitions from current to former smoking were associated with recovery from other substance use disorders. River City Recovery’s outpatient program descriptions and care coordination information explain available care structures and referral support, not a promise that every health concern is treated within those programs.
The researchers used the Population Assessment of Tobacco and Health, or PATH, Study, an ongoing national survey. Their primary analysis examined changes within the same people over time. Rather than only comparing one group of smokers with a separate group of former smokers, the analysis asked whether a person’s smoking status and recovery status changed together across survey waves.
The study’s methods and results provide several details that matter when interpreting the finding:
Understanding the 2025 smoking and recovery study
| Study feature | What researchers measured | Why it matters |
|---|---|---|
| Primary sample | 2,652 adults with a lifetime substance-use disorder history whose recovery status changed during follow-up. | The analysis did not include every adult with a substance-use history. |
| Observation period | Annual assessments from 2013/2014 through 2016/2018. | This was longitudinal survey research, not an assigned cessation treatment. |
| Recovery outcome | High lifetime symptoms, defined as four to seven, with no substance-use symptoms or use in the past year. | The outcome was a specific survey definition, not every dimension of recovery. |
| Adjusted finding | Transitioning to former smoking was associated with 30% higher odds of recovery. | Higher odds are not the same as a 30-percentage-point increase in recovery probability. |
The adjusted odds ratio was 1.30. That number describes an association in the study population. It cannot tell an individual how likely they are to recover, how quickly change will occur, or whether tobacco cessation caused another substance-use outcome.
What does nicotine dependence mean?
Nicotine is the drug primarily responsible for addiction to tobacco products, according to the National Cancer Institute’s explanation of smoking and dependence. Dependence is a health concern, not a moral failing. River City Recovery’s clinical and medical assessment information and admissions overview describe conversations about substance use, medications, health context, and goals without treating assessment as a test someone passes or fails.
NCI explains that nicotine occurs naturally in tobacco and reaches the brain quickly after absorption through the mouth or lungs. The amount absorbed depends on both the product and how someone uses it. The FDA’s cessation guidance also notes that nicotine can keep people using tobacco even when they want to stop.
Recognizing dependence does not establish an individual diagnosis from smoking status alone. It also does not reveal whether someone is making progress with alcohol or another drug. The study measured cigarette smoking and non-tobacco substance-use recovery separately. Those distinct measures should not be collapsed into a single judgment about a person.
Three distinctions can keep the conversation clearer:
- Tobacco exposure concerns health effects. Cigarette smoke contains harmful chemicals, and other tobacco products also carry health risks.
- Nicotine dependence concerns continued use. Wanting to stop and finding it difficult can coexist; difficulty does not demonstrate a lack of concern.
- Other substance-use recovery is a separate concern. Smoking status alone does not establish someone’s symptoms, treatment participation, or progress regarding another substance.
A useful conversation can begin with accurate information about what tobacco products someone uses and what questions they have. There is no need to attach a label before asking for help. Personal assessment, rather than assumptions about motivation, belongs at the center of care planning.
What health effects and benefits of quitting are established?
Smoking causes serious disease, and quitting reduces health risks regardless of age, according to the NCI fact sheet on smoking harms and quitting benefits. These established benefits are separate from the observational recovery finding. River City Recovery’s program overview and coordination and referral information describe outpatient services and possible next steps when additional care is needed.
NCI reports that cigarette smoking harms nearly every organ and organ system. It causes multiple cancers, heart disease, stroke, and chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. Smoking also worsens asthma symptoms in adults. These are population-level health findings, not a diagnosis or prediction about which condition a particular person will develop.
Quitting reduces the risk of cancer and other smoking-related diseases. NCI describes improvements in circulation and respiratory symptoms after quitting, as well as lower long-term risks compared with continued smoking. The practical message does not depend on promising an exact personal timeline: health benefits remain possible even after years of smoking, and older adults can benefit too.
Smoking only a few cigarettes is not risk-free. NCI states that there is no safe level of smoking and that all forms of tobacco are harmful and addictive. Switching to cigars, pipes, hookah, or smokeless tobacco should not be presented as removing tobacco-related risk. Different products have different exposures, but none becomes safe simply because it is not a cigarette.
Secondhand smoke is relevant when tobacco use affects shared spaces. NCI identifies it as a cause of disease in nonsmoking adults and children, including lung cancer in adults and increased respiratory problems in children. Discussing smoke exposure can therefore include household health without assigning blame or using family concerns to pressure someone into a treatment decision.
What kinds of cessation support are available?
Counseling and FDA-approved or FDA-cleared cessation products are options to discuss with a health professional. The FDA’s product overview explains their general roles and safety considerations. River City Recovery’s assessment page and admissions information establish its general outpatient assessment process; they do not establish that it provides tobacco cessation counseling, particular cessation prescriptions, or cessation devices.
NCI identifies individualized counseling, information, and referrals among available quitting resources. The FDA reports that nicotine replacement therapy used with a behavioral program can increase smoking cessation success. This supports asking about both behavioral and medication-related assistance rather than assuming that quitting must rely on willpower alone. It does not select an approach for any individual.
Nicotine replacement therapy, often called NRT, provides nicotine without the toxic chemicals found in cigarette smoke. The FDA lists skin patches, gum, and lozenges as over-the-counter options for adults. Prescription nicotine products include a spray and an inhaler. These product categories differ in how they are used; choosing among them and following their instructions requires attention to the person’s circumstances and the product label.
The FDA also identifies two approved prescription smoking cessation medicines that do not contain nicotine: varenicline tartrate and bupropion hydrochloride. They have potential risks and side effects. The FDA advises discussing health history and other relevant circumstances with a health professional. Its guidance specifically notes that varenicline may change how someone reacts to alcohol, making an accurate discussion of drinking habits important.
Questions for a clinician or pharmacist may include:
- How do my medical history and current health concerns affect the options?
- What should you know about my current medications and substance use?
- Do pregnancy or breastfeeding affect which approaches should be considered?
- What side effects should I understand, and whom should I contact if they occur?
- Where can I obtain counseling or behavioral support that fits my circumstances?
The FDA has also cleared a device using transcranial magnetic stimulation as an aid for short-term smoking cessation in adults. Device clearance is different from drug approval, and neither establishes that a specific provider offers the treatment. This category belongs in a discussion of available options, not a recommendation to seek a device over counseling or medication.
The cigarette-smoking study did not establish vaping as a cessation treatment. Its authors identified other nicotine products, including e-cigarettes, as topics for future research. Its findings should not be used to present vaping as a proven way to quit smoking or improve recovery from another substance-use disorder.
What can the study show, and where does care fit?
The study supports an association, not proof that quitting smoking caused recovery. Understanding that limit helps keep treatment conversations realistic. River City Recovery’s admissions guidance for loved ones explains supportive involvement, while its contact information offers a route to ask about available outpatient care. Neither a research result nor a first conversation guarantees admission, access to a cessation service, or a particular outcome.
The study’s limitations section states that researchers had no direct measure of substance-use treatment or related medications, such as anticraving prescriptions. They accounted for medical visits and some other medication use, but could not fully describe the addiction treatment participants received. All measures were self-reported, and other changing influences may not have been captured.
Timing also matters. In the primary analysis, smoking and recovery status were assessed within the same 12-month period. The main question was whether recovery was more likely during years when participants were not smoking, not whether quitting necessarily came first. Additional analyses examining timing and a later cohort found similar associations, but those checks did not turn the observational study into a randomized trial.
The recovery measure was also narrow: sustained remission based on the survey’s symptom and use criteria. The authors state that results generalize to that outcome, not automatically to reductions in use or other recovery measures. The primary analysis additionally required recovery status to change, which is important when considering who the findings describe.
The guide to what evidence-based addiction treatment means in GA explains why research support, actual service availability, and individual fit are separate questions. That distinction is useful here: a smoking study does not verify a facility’s cessation services, and evidence supporting a product does not establish that it fits someone’s health needs.
River City Recovery provides adult outpatient addiction and mental health care in Columbus, GA. Published options include PHP, IOP, Evening IOP, and outpatient therapy. Services may include assessments, individual therapy, medication management, family support, and care coordination. These general listings do not establish a tobacco treatment program or the availability of a specific cessation prescription.
Someone considering outpatient care can ask which concerns the program can address and whether an outside referral may be appropriate. Referrals do not guarantee another provider’s availability or admission. Tobacco questions can remain part of a broader health conversation while decisions about substance-use care continue to reflect assessed needs, personal goals, and the services actually available.
Frequently asked questions
Can tobacco cessation be considered during substance-use recovery?
Yes. The 2025 study places tobacco cessation within substance-use care and cites SAMHSA’s national survey of treatment facilities. It also reports that tobacco treatment is often absent in these settings. That context supports asking about options, not assuming every program offers them or that cessation will improve any particular person’s recovery outcome.
Does nicotine dependence mean someone has failed at recovery?
No. Nicotine dependence is a health concern, not a measure of character or commitment. Smoking status alone does not establish an individual diagnosis or determine progress with another substance. Tobacco use and other substance-use concerns deserve separate, nonjudgmental assessment, with attention to the person’s health, goals, and questions rather than a pass-or-fail label.
What support options exist for quitting tobacco?
Options include counseling, behavioral support, and FDA-approved smoking cessation products, including nicotine replacement and prescription medicines without nicotine. The FDA has also cleared a device for short-term cessation assistance in adults. Product choice and safety require personal health guidance. These general options do not mean River City Recovery provides tobacco cessation treatment or any particular product.
What did a recent study find about quitting smoking and recovery?
A 2025 longitudinal study analyzed 2,652 adults with a substance-use disorder history whose recovery status changed during follow-up. Moving from current to former cigarette smoking was associated with 30% higher adjusted odds of recovery, defined through past-year symptom and use measures. The observational association does not prove that quitting caused recovery or predict an individual’s outcome.

